We are live on ! Find out more
MMRF

Michelson Medical Research Foundation Portfolio holdings

AUM $108M
1-Year Est. Return 29.95%
This Fund
S&P 500
This Quarter Est. Return
-4.31%
1 Year Est. Return
+29.95%
3 Year Est. Return
+52.22%
5 Year Est. Return
10 Year Est. Return
AUM
$119M
AUM Growth
-$22.5M
Cap. Flow
-$16.3M
Cap. Flow %
-13.63%
Top 10 Hldgs %
66.31%
Holding
29
New
1
Increased
2
Reduced
7
Closed
1

Top Buys

Rank Stock Value
1
MTN icon
Vail Resorts
MTN
+$6.44M
2
EL icon
Estee Lauder
EL
+$6.32M
3
CMP icon
Compass Minerals
CMP
+$1.24M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.51%
2 Real Estate 9.31%
3 Materials 5.66%
4 Consumer Staples 5.03%
5 Industrials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTN icon
1
Vail Resorts
MTN
$5.32B
$16.1M 13.51%
86,000
+36,000
+72% +$6.44M
IVE icon
2
iShares S&P 500 Value ETF
IVE
$50.3B
$9.91M 8.3%
51,905
IVV icon
3
iShares Core S&P 500 ETF
IVV
$893B
$8.82M 7.4%
14,989
GDX icon
4
VanEck Gold Miners ETF
GDX
$32.1B
$7.95M 6.66%
234,305
VEA icon
5
Vanguard FTSE Developed Markets ETF
VEA
$239B
$7.56M 6.34%
158,160
-203,000
-56% -$10.2M
CMP icon
6
Compass Minerals
CMP
$1.04B
$6.75M 5.66%
600,000
+95,000
+19% +$1.24M
EL icon
7
Estee Lauder
EL
$38B
$6M 5.03%
+80,000
New +$6.32M
IBB icon
8
iShares Biotechnology ETF
IBB
$10.9B
$5.74M 4.81%
43,395
VWO icon
9
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$5.62M 4.71%
127,630
-109,000
-46% -$5.07M
KRE icon
10
State Street SPDR S&P Regional Banking ETF
KRE
$4.06B
$4.65M 3.9%
77,100
-37,600
-33% -$2.33M
IWC icon
11
iShares Micro-Cap ETF
IWC
$1.52B
$4.61M 3.87%
35,385
RTO icon
12
Rentokil
RTO
$11.8B
$4.56M 3.82%
180,000
ARE icon
13
Alexandria Real Estate Equities
ARE
$9.07B
$3.63M 3.04%
37,230
PLD icon
14
Prologis
PLD
$135B
$2.97M 2.49%
28,077
-14,328
-34% -$1.65M
XBI icon
15
State Street SPDR S&P Biotech ETF
XBI
$11.8B
$2.82M 2.36%
31,300
VB icon
16
Vanguard Morningstar Small-Cap ETF
VB
$82.2B
$2.65M 2.22%
11,010
-7,900
-42% -$1.94M
SUI icon
17
Sun Communities
SUI
$15.2B
$2.46M 2.06%
20,000
-30,000
-60% -$3.84M
BUR icon
18
Burford Capital
BUR
$949M
$2.29M 1.92%
180,000
CRGY icon
19
Crescent Energy
CRGY
$4.42B
$2.28M 1.91%
156,166
EWW icon
20
iShares MSCI Mexico ETF
EWW
$1.8B
$1.96M 1.64%
41,850
EWZ icon
21
iShares MSCI Brazil ETF
EWZ
$8.21B
$1.83M 1.53%
81,300
BXP icon
22
Boston Properties
BXP
$11.3B
$1.62M 1.35%
21,735
EWT icon
23
iShares MSCI Taiwan ETF
EWT
$11.6B
$1.42M 1.19%
27,435
EWJ icon
24
iShares MSCI Japan ETF
EWJ
$22.6B
$1.35M 1.13%
20,100
GXC icon
25
State Street SPDR S&P China ETF
GXC
$472M
$1.27M 1.07%
16,750

Similar funds

Michelson Medical Research Foundation's Q4 2024 Portfolio in Review

As of Q4 2024, Michelson Medical Research Foundation held 29 positions worth $119M, down 16% from $142M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Michelson Medical Research Foundation withdrew a net $16.3M in Q4 2024, closing 1 position and reducing 7 holdings. Its most notable exit was EPAM Systems, an estimated $1.99M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 6.1% a quarter earlier, followed by Real Estate and Materials.

Against the trend, Michelson Medical Research Foundation opened a new position in Estee Lauder worth $6M.

  • Michelson Medical Research Foundation's largest Q4 2024 buy was Estee Lauder: 80,000 shares worth $6M.
  • Michelson Medical Research Foundation added most to Vail Resorts in Q4 2024, an estimated $6.44M increase.
  • Michelson Medical Research Foundation's biggest Q4 2024 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $10.2M.
  • Michelson Medical Research Foundation fully exited EPAM Systems in Q4 2024, selling an estimated $1.99M.
  • Michelson Medical Research Foundation's ten largest holdings make up 66% of its $119M portfolio in Q4 2024.
  • Michelson Medical Research Foundation opened 1 new position and closed 1 in Q4 2024.
  • Michelson Medical Research Foundation's portfolio value fell 16% quarter-over-quarter to $119M.

Based on Michelson Medical Research Foundation's 13F filing for Q4 2024, filed 14 Feb 2025.